Lexicon Pharmaceuticals Inc

Healthcare · Biotechnology

1.80$ -2.9% vs. previous close Closing price · As of: Oct 1, 2026

Statements

Balance Sheet

Lexicon Pharmaceuticals Inc (LXRX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 250 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet LXRX
Line item	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	276	229	417	373	321	298	298	226	206	185	269	250
Current Assets	223	177	365	321	269	246	246	145	123	102	186	197
Cash	21	22	96	36	35	67	63	21	50	34	38	41
Cash & Short-Term Investments	218	170	356	310	258	238	195	139	116	96	171	191
Receivables	0.3	1.0	1.5	2.6	2.9	3.5	47	2.2	2.3	2.4	12	1.6
Inventory	0.3	0.4	0.5	0.6	0.6	0.2	0.2	0.2	0.2	0.3	0.3	1.2
Goodwill	45	45	45	45	45	45	45	45	45	45	45	45
Total Liabilities	137	136	128	133	143	152	175	96	86	77	66	76
Current Liabilities	32	32	23	28	36	45	111	35	22	21	9.9	15
Short-Term Debt	1.3	1.3	1.3	1.3	1.3	1.2	43	0.9	1.6	6.2	1.6	1.6
Accounts Payable	12	14	8.1	12	14	15	11	5.9	3.8	3.1	3.0	2.3
Long-Term Debt	99	100	100	99	100	100	59	56	57	49	50	51
Shareholders' Equity	140	93	289	240	179	146	123	129	120	108	203	175
Retained Earnings	-1,717	-1,767	-1,815	-1,869	-1,933	-1,967	-1,993	-1,989	-2,002	-2,018	-2,019	-2,050
Shares Outstanding	245	245	245	311	361	361	362	364	363	363	400	438

Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings